Selected article for: "antiviral treatment and specific antiviral treatment"
Author: Caracciolo, Massimo; Correale, Pierpaolo; Mangano, Carmelo; Foti, Giuseppe; Falcone, Carmela; Macheda, Sebastiano; Cuzzola, Maria; Conte, Marco; Falzea, Antonella Consuelo; Iuliano, Eleonora; Morabito, Antonella; Caraglia, Michele; Polimeni, Nicola; Ferrarelli, Anna; Labate, Demetrio; Tescione, Marco; Di Renzo, Laura; Chiricolo, Gaetano; Romano, Lorenzo; De Lorenzo, Antonino
Title: Efficacy and Effect of Inhaled Adenosine Treatment in Hospitalized COVID-19 Patients
  • Cord-id: tip74t3b
  • Document date: 2021_3_18
    • ID: tip74t3b
    Snippet: Lack of specific antiviral treatment for COVID-19 has resulted in long hospitalizations and high mortality rate. By harnessing the regulatory effects of adenosine on inflammatory mediators, we have instituted a new therapeutic treatment with inhaled adenosine in COVID-19 patients, with the aim of reducing inflammation, the onset of cytokine storm, and therefore to improve prognosis. The use of inhaled adenosine in COVID19 patients has allowed reduction of length of stay, on average 6 days. This
    Document: Lack of specific antiviral treatment for COVID-19 has resulted in long hospitalizations and high mortality rate. By harnessing the regulatory effects of adenosine on inflammatory mediators, we have instituted a new therapeutic treatment with inhaled adenosine in COVID-19 patients, with the aim of reducing inflammation, the onset of cytokine storm, and therefore to improve prognosis. The use of inhaled adenosine in COVID19 patients has allowed reduction of length of stay, on average 6 days. This result is strengthened by the decrease in SARS-CoV-2 positive days. In treated patients compared to control, a clear improvement in PaO(2)/FiO(2) was observed together with a reduction in inflammation parameters, such as the decrease of CRP level. Furthermore, the efficacy of inhaled exogenous adenosine led to an improvement of the prognosis indices, NLR and PLR. The treatment seems to be safe and modulates the immune system, allowing an effective response against the viral infection progression, reducing length of stay and inflammation parameters.

    Search related documents:
    Co phrase search for related documents
    • action exert and acute respiratory syndrome: 1, 2
    • activate immune cell and acute inflammation: 1
    • activate immune cell and acute respiratory syndrome: 1
    • active molecule and acute respiratory syndrome: 1, 2, 3, 4, 5
    • active ventilation and acute ards respiratory distress syndrome: 1, 2
    • active ventilation and acute inflammation: 1
    • active ventilation and acute lung injury: 1
    • active ventilation and acute respiratory syndrome: 1, 2, 3
    • active ventilation and adenosine beneficial effect: 1
    • active ventilation and adenosine effect: 1
    • acute ards respiratory distress syndrome and additional information: 1, 2, 3
    • acute ards respiratory distress syndrome and additional therapy: 1, 2
    • acute ards respiratory distress syndrome and adenosine beneficial effect: 1
    • acute inflammation and additional information: 1
    • acute inflammation and adenosine beneficial effect: 1
    • acute lung injury and additional information: 1, 2
    • acute respiratory syndrome and additional information: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory syndrome and additional therapy: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • acute respiratory syndrome and adenosine ar: 1